Dr. Stephen Petteruti │ Skip the Prostate Biopsy: PSA, MRI & Testosterone Therapy Explained

What if everything men are told about a prostate cancer diagnosis, biopsy first, surgery next, is built on evidence that was never actually there?

In this episode of Integrative Cancer Solutions, Dr. K sits down with Dr. Stephen Petteruti, board certified family physician and author of Fight Cancer Like a Man, to break down the 2023 New England Journal of Medicine study that found no survival difference between surgery, radiation, and doing nothing at all for early stage prostate cancer. Dr. Petteruti explains why he stopped recommending biopsies, how a needle can spread the very cancer it's meant to detect, and why watching PSA and MRI trends over time is often safer than rushing into treatment. He also covers the overlooked role of testosterone in prostate cancer care, including bipolar androgen therapy, and makes the case for tracking the disease like a chronic condition instead of chasing a cure that costs a man his vitality.

If you or someone you love is facing a prostate cancer diagnosis, or just navigating an elevated PSA, this conversation lays out the questions worth asking before agreeing to anything.

Key Takeaways:

0:00 Introduction

2:33 The prostate trial that shattered the surgery-first model

5:19 Why a biopsy can spread the very cancer it's meant to find

8:23 Castration's hidden cost on testosterone and quality of life

17:12 Tracking prostate cancer with MRI and PSA instead of biopsy

21:58 Repurposed drugs and why DIY protocols backfire

38:10 BAM therapy: using testosterone as a weapon against advanced cancer

Schedule a Free 15-Min Cancer/Lyme Consultation at The Karlfeldt Center: 208-338-8902